Ludwig Cancer Research and CRI collaborate on VentiRx's investigational immunotherapy
The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial ...
Sep 3, 2014
0
0